Devi Pharmatech Profile
Key Indicators
- Authorised Capital ₹ 40.00 Cr
as on 09-12-2024
- Paid Up Capital ₹ 40.00 Cr
as on 09-12-2024
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 60.21 Cr
as on 09-12-2024
- Revenue %
(FY 2023)
- Ebitda -447.78%
(FY 2023)
- Net Worth 1100.00%
(FY 2023)
- Total Assets 137.19%
(FY 2023)
About Devi Pharmatech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 40.00 Cr and a paid-up capital of Rs 40.00 Cr.
The company currently has active open charges totaling ₹60.21 Cr.
The Key Managerial Personnel (KMP) at Devi Pharmatech Private Limited India are Sirish Ravula as CEO and Ayush Shukla as Company Secretary. Sirish Ravula, Ravi Yerra, Indraneel Chitturi, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24100AP2020PTC116039
- Company No.
116039
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Devi Pharmatech?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sirish Ravula | CEO | 30-Sep-2022 | Current |
| Ayush Shukla | Company Secretary | 30-Jul-2024 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sirish Ravula  | Director | 01-Oct-2022 | Current |
| Ravi Yerra | Director | 01-Oct-2022 | Current |
| Veerendra Yarlagadda | Director | 13-Mar-2021 | Current |
| Indraneel Chitturi | Director | 20-Oct-2021 | Current |
| Mahendra Yarlagadda | Director | 13-Oct-2020 | Current |
| Sri Yarlagadda | Director | 20-Oct-2021 | Current |
Financial Performance and Corporate Structure Insights of Devi Pharmatech.
Devi Pharmatech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 1100%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Devi Pharmatech?
In 2023, Devi Pharmatech had a promoter holding of 21.33% and a public holding of 78.66%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Devi Fisheries LimitedActive 27 years 7 monthsIndraneel Chitturi and Mahendra Yarlagadda are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 19 Nov 2022 | ₹2.10 M | Open |
Hdfc Bank Limited Creation Date: 21 May 2022 | ₹60.00 Cr | Open |
How Many Employees Work at Devi Pharmatech?
Devi Pharmatech has a workforce of 105 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Devi Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Devi Pharmatech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
